A citation-based method for searching scientific literature

Pathan Shahebaaz Khan, Patil Rajesh, Patil Rajendra, Manohar G Chaskar, Arote Rohidas, Sangshetti Jaiprakash. Bioorg Chem 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Toward the estimation of the absolute quality of individual protein structure models.
Pascal Benkert, Marco Biasini, Torsten Schwede. Bioinformatics 2011
50

Substituted 2-phenyl-benzimidazole derivatives: novel compounds that suppress key markers of allergy.
Mark L Richards, Shirley Cruz Lio, Anjana Sinha, Homayon Banie, Richard J Thomas, Michael Major, Mark Tanji, Jagadish C Sircar. Eur J Med Chem 2006
14
50

Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Mona A Abdullaziz, Heba T Abdel-Mohsen, Ahmed M El Kerdawy, Fatma A F Ragab, Mamdouh M Ali, Sherifa M Abu-Bakr, Adel S Girgis, Hoda I El Diwani. Eur J Med Chem 2017
35
50

Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities.
Hanan A Bashmail, Aliaa A Alamoudi, Abdulwahab Noorwali, Gehan A Hegazy, Ghada AJabnoor, Hani Choudhry, Ahmed M Al-Abd. Sci Rep 2018
52
50

Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology.
Martino Bertoni, Florian Kiefer, Marco Biasini, Lorenza Bordoli, Torsten Schwede. Sci Rep 2017
356
50

Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity.
Mohammed S Abdel-Maksoud, Mohammed I El-Gamal, Bong S Lee, Mahmoud M Gamal El-Din, Hong R Jeon, Dow Kwon, Usama M Ammar, Karim I Mersal, Eslam M H Ali, Kyung-Tae Lee,[...]. J Med Chem 2021
9
50

SWISS-MODEL: homology modelling of protein structures and complexes.
Andrew Waterhouse, Martino Bertoni, Stefan Bienert, Gabriel Studer, Gerardo Tauriello, Rafal Gumienny, Florian T Heer, Tjaart A P de Beer, Christine Rempfer, Lorenza Bordoli,[...]. Nucleic Acids Res 2018
50

Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF.
Eric A Murphy, David J Shields, Konstantin Stoletov, Elena Dneprovskaia, Michele McElroy, Joshua I Greenberg, Jeff Lindquist, Lisette M Acevedo, Sudarshan Anand, Bharat Kumar Majeti,[...]. Proc Natl Acad Sci U S A 2010
44
50


Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.
Jayesh Desai, Hui Gan, Catherine Barrow, Michael Jameson, Victoria Atkinson, Andrew Haydon, Michael Millward, Stephen Begbie, Michael Brown, Ben Markman,[...]. J Clin Oncol 2020
34
50


Current Insights of BRAF Inhibitors in Cancer.
Bogos Agianian, Evripidis Gavathiotis. J Med Chem 2018
46
50

Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors.
Heba T Abdel-Mohsen, Mohamed A Omar, Ahmed M El Kerdawy, Abeer E E Mahmoud, Mamdouh M Ali, Hoda I El Diwani. Eur J Med Chem 2019
22
50

Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents.
Vikram Jeet Singh, Bharti Sharma, Pooja A Chawla. Bioorg Chem 2021
6
50


Selective Raf inhibition in cancer therapy.
Vladimir Khazak, Igor Astsaturov, Ilya G Serebriiskii, Erica A Golemis. Expert Opin Ther Targets 2007
56
50

Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors.
Hans-Peter Buchstaller, Lars Burgdorf, Dirk Finsinger, Frank Stieber, Christian Sirrenberg, Christiane Amendt, Matthias Grell, Frank Zenke, Mireille Krier. Bioorg Med Chem Lett 2011
7
50

Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Siu T Yuen, Helen Davies, Tsun L Chan, Judy W Ho, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Wendy W Tsui, Annie S Chan,[...]. Cancer Res 2002
353
50

KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Timothy H Tran, Albert H Chan, Lucy C Young, Lakshman Bindu, Chris Neale, Simon Messing, Srisathiyanarayanan Dharmaiah, Troy Taylor, John-Paul Denson, Dominic Esposito,[...]. Nat Commun 2021
45
50

Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro.
Omar M Alaufi, Abdulwahab Noorwali, Fatheya Zahran, Ahmed M Al-Abd, Safia Al-Attas. Sci Rep 2017
39
50

Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives.
Ahmed I Khodair, Mona A Alsafi, Mohamed S Nafie. Carbohydr Res 2019
17
50

Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.
Gisele A Nishiguchi, Alice Rico, Huw Tanner, Robert J Aversa, Benjamin R Taft, Sharadha Subramanian, Lina Setti, Matthew T Burger, Lifeng Wan, Victoriano Tamez,[...]. J Med Chem 2017
30
50



VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.
Valentina Comunanza, Davide Corà, Francesca Orso, Francesca Maria Consonni, Emanuele Middonti, Federica Di Nicolantonio, Anton Buzdin, Antonio Sica, Enzo Medico, Dario Sangiolo,[...]. EMBO Mol Med 2017
25
50

Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells.
Rasha M Allam, Ahmed M Al-Abd, Alaa Khedr, Ola A Sharaf, Salwa M Nofal, Amani E Khalifa, Hisham A Mosli, Ashraf B Abdel-Naim. Toxicol Lett 2018
56
50

New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Nesrin Gökhan-Kelekçi, Semra Koyunoğlu, Samiye Yabanoğlu, Kemal Yelekçi, Ozen Ozgen, Gülberk Uçar, Kevser Erol, Engin Kendi, Akgül Yeşilada. Bioorg Med Chem 2009
62
50

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford,[...]. Cell 2004
50

Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes.
C K Weber, J R Slupsky, C Herrmann, M Schuler, U R Rapp, C Block. Oncogene 2000
57
50

Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors.
Abdallah E Abdallah, Reda R Mabrouk, Maged Mohammed Saleh Al Ward, Sally I Eissa, Eslam B Elkaeed, Ahmed B M Mehany, Mariam A Abo-Saif, Ola A El-Feky, Mohamed S Alesawy, Mohamed Ayman El-Zahabi. J Enzyme Inhib Med Chem 2022
6
50


Discovery of Novel Small-Molecule Antiangiogenesis Agents to Treat Diabetic Retinopathy.
Donghwa Kim, Sang Won Choi, Jihee Cho, Jae-Hui Been, Kyoungsun Choi, Wenzhe Jiang, Jaeho Han, Jedo Oh, Changmin Park, Soongyu Choi,[...]. J Med Chem 2021
5
50

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.
Osama M Soltan, Mai E Shoman, Salah A Abdel-Aziz, Atsushi Narumi, Hiroyuki Konno, Mohamed Abdel-Aziz. Eur J Med Chem 2021
7
50

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.
J M Cherrington, L M Strawn, L K Shawver. Adv Cancer Res 2000
153
50

FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia.
Bertrand W Parcells, Alan K Ikeda, Tiffany Simms-Waldrip, Theodore B Moore, Kathleen M Sakamoto. Stem Cells 2006
78
50

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors.
Michele McTigue, Brion William Murray, Jeffrey H Chen, Ya-Li Deng, James Solowiej, Robert S Kania. Proc Natl Acad Sci U S A 2012
219
50

Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
Mohammed S Abdel-Maksoud, Rasha Mohamed Hassan, Aida Abdel-Sattar El-Azzouny, Mohamed Nabil Aboul-Enein, Chang-Hyun Oh. Bioorg Chem 2021
1
100

Angiogenesis inhibitors: current strategies and future prospects.
Kristina M Cook, William D Figg. CA Cancer J Clin 2010
341
50

Identification of a New Heterocyclic Scaffold for Inhibitors of the Polo-Box Domain of Polo-like Kinase 1.
Celeste N Alverez, Jung-Eun Park, Kiran S Toti, Yangliu Xia, Kristopher W Krausz, Ganesha Rai, Jeong K Bang, Frank J Gonzalez, Kenneth A Jacobson, Kyung S Lee. J Med Chem 2020
5
50

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers.
Zhiyu Tang, Xi Yuan, Rong Du, Shing-Hu Cheung, Guoliang Zhang, Jing Wei, Yuan Zhao, Yingcai Feng, Hao Peng, Yi Zhang,[...]. Mol Cancer Ther 2015
44
50

Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1,4-benzodioxines.
Rasha Mohamed Hassan, Walaa Hamada Abd-Allah, Asmaa Mohamed Salman, Aida Abdel-Sattar El-Azzouny, Mohamed Nabil Aboul-Enein. Eur J Pharm Sci 2019
18
50


Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells.
Zhen Li, Ke Jiang, Xiaofang Zhu, Guibin Lin, Fei Song, Yongfu Zhao, Yongjun Piao, Jiwei Liu, Wei Cheng, Xiaolin Bi,[...]. Cancer Lett 2016
59
50

The SWISS-MODEL Repository-new features and functionality.
Stefan Bienert, Andrew Waterhouse, Tjaart A P de Beer, Gerardo Tauriello, Gabriel Studer, Lorenza Bordoli, Torsten Schwede. Nucleic Acids Res 2017
712
50

Synthesis, molecular docking study and antitumor activity of novel 2-phenylindole derivatives.
Sally S El-Nakkady, Mona M Hanna, Hanaa M Roaiah, Iman A Y Ghannam. Eur J Med Chem 2012
23
50


Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma.
Teresa E Williams, Sharadha Subramanian, Joelle Verhagen, Christopher M McBride, Abran Costales, Leonard Sung, William Antonios-McCrea, Maureen McKenna, Alicia K Louie, Savithri Ramurthy,[...]. ACS Med Chem Lett 2015
22
50


Benzimidazoles from Aryl Alkyl Ketones and 2-Amino Anilines by an Iodine Catalyzed Oxidative C(CO)-C(alkyl) Bond Cleavage.
Owk Ravi, Altab Shaikh, Atul Upare, Kiran Kumar Singarapu, Surendar Reddy Bathula. J Org Chem 2017
9
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.